338 related articles for article (PubMed ID: 24638982)
1. Myeloid WNT7b mediates the angiogenic switch and metastasis in breast cancer.
Yeo EJ; Cassetta L; Qian BZ; Lewkowich I; Li JF; Stefater JA; Smith AN; Wiechmann LS; Wang Y; Pollard JW; Lang RA
Cancer Res; 2014 Jun; 74(11):2962-73. PubMed ID: 24638982
[TBL] [Abstract][Full Text] [Related]
2. Attenuated transforming growth factor beta signaling promotes metastasis in a model of HER2 mammary carcinogenesis.
Novitskiy SV; Forrester E; Pickup MW; Gorska AE; Chytil A; Aakre M; Polosukhina D; Owens P; Yusupova DR; Zhao Z; Ye F; Shyr Y; Moses HL
Breast Cancer Res; 2014 Oct; 16(5):425. PubMed ID: 25280532
[TBL] [Abstract][Full Text] [Related]
3. Extracellular vesicular Wnt7b mediates HPV E6-induced cervical cancer angiogenesis by activating the β-catenin signaling pathway.
Qiu JJ; Sun SG; Tang XY; Lin YY; Hua KQ
J Exp Clin Cancer Res; 2020 Nov; 39(1):260. PubMed ID: 33234148
[TBL] [Abstract][Full Text] [Related]
4. miR-199a-5p modulates choroidal neovascularization by regulating Wnt7b/Wnt/β-catenin signaling pathway.
Geng Y; Hua H; Xia Y; Zhou J; He J; Xu X; Zhao J
J Mol Histol; 2024 Jun; 55(3):359-370. PubMed ID: 38662168
[TBL] [Abstract][Full Text] [Related]
5. A Wnt-ow of opportunity: targeting the Wnt/beta-catenin pathway in breast cancer.
Prosperi JR; Goss KH
Curr Drug Targets; 2010 Sep; 11(9):1074-88. PubMed ID: 20545611
[TBL] [Abstract][Full Text] [Related]
6. Stromally derived lysyl oxidase promotes metastasis of transforming growth factor-β-deficient mouse mammary carcinomas.
Pickup MW; Laklai H; Acerbi I; Owens P; Gorska AE; Chytil A; Aakre M; Weaver VM; Moses HL
Cancer Res; 2013 Sep; 73(17):5336-46. PubMed ID: 23856251
[TBL] [Abstract][Full Text] [Related]
7. FRAT1 promotes the angiogenic properties of human glioblastoma cells via VEGFA.
Yang B; Liu D; Ren YQ; Sun YQ; Zhang JP; Wang XG; Wu YQ; Wang SL; Guo SH; Guo G
Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35059733
[TBL] [Abstract][Full Text] [Related]
8. GPNMB augments Wnt-1 mediated breast tumor initiation and growth by enhancing PI3K/AKT/mTOR pathway signaling and β-catenin activity.
Maric G; Annis MG; MacDonald PA; Russo C; Perkins D; Siwak DR; Mills GB; Siegel PM
Oncogene; 2019 Jun; 38(26):5294-5307. PubMed ID: 30914799
[TBL] [Abstract][Full Text] [Related]
9. Early vascular deficits are correlated with delayed mammary tumorigenesis in the MMTV-PyMT transgenic mouse following genetic ablation of the NG2 proteoglycan.
Gibby K; You WK; Kadoya K; Helgadottir H; Young LJ; Ellies LG; Chang Y; Cardiff RD; Stallcup WB
Breast Cancer Res; 2012 Apr; 14(2):R67. PubMed ID: 22531600
[TBL] [Abstract][Full Text] [Related]
10. WNT7A/B promote choroidal neovascularization.
Lin JB; Sene A; Wiley LA; Santeford A; Nudleman E; Nakamura R; Lin JB; Moolani HV; Apte RS
Exp Eye Res; 2018 Sep; 174():107-112. PubMed ID: 29864439
[TBL] [Abstract][Full Text] [Related]
11. Activating transcription factor 4 promotes angiogenesis of breast cancer through enhanced macrophage recruitment.
Liu C; Li Z; Wang L; Tong L; He N; Chen Y; Liu Y; Wu Z; Sun P; Xiang R; Ren G; Su W
Biomed Res Int; 2015; 2015():974615. PubMed ID: 25883982
[TBL] [Abstract][Full Text] [Related]
12. Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis.
Stockmann C; Doedens A; Weidemann A; Zhang N; Takeda N; Greenberg JI; Cheresh DA; Johnson RS
Nature; 2008 Dec; 456(7223):814-8. PubMed ID: 18997773
[TBL] [Abstract][Full Text] [Related]
13. Breast tumor cell TACE-shed MCSF promotes pro-angiogenic macrophages through NF-κB signaling.
Rego SL; Helms RS; Dréau D
Angiogenesis; 2014 Jul; 17(3):573-85. PubMed ID: 24197832
[TBL] [Abstract][Full Text] [Related]
14. Activation of the canonical Wnt/β-catenin pathway in ATF3-induced mammary tumors.
Yan L; Della Coletta L; Powell KL; Shen J; Thames H; Aldaz CM; MacLeod MC
PLoS One; 2011 Jan; 6(1):e16515. PubMed ID: 21304988
[TBL] [Abstract][Full Text] [Related]
15. Apelin inhibition prevents resistance and metastasis associated with anti-angiogenic therapy.
Uribesalgo I; Hoffmann D; Zhang Y; Kavirayani A; Lazovic J; Berta J; Novatchkova M; Pai TP; Wimmer RA; László V; Schramek D; Karim R; Tortola L; Deswal S; Haas L; Zuber J; Szűcs M; Kuba K; Dome B; Cao Y; Haubner BJ; Penninger JM
EMBO Mol Med; 2019 Aug; 11(8):e9266. PubMed ID: 31267692
[TBL] [Abstract][Full Text] [Related]
16. Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer.
Straume O; Shimamura T; Lampa MJ; Carretero J; Øyan AM; Jia D; Borgman CL; Soucheray M; Downing SR; Short SM; Kang SY; Wang S; Chen L; Collett K; Bachmann I; Wong KK; Shapiro GI; Kalland KH; Folkman J; Watnick RS; Akslen LA; Naumov GN
Proc Natl Acad Sci U S A; 2012 May; 109(22):8699-704. PubMed ID: 22589302
[TBL] [Abstract][Full Text] [Related]
17. Wnt-5a-CKI{alpha} signaling promotes {beta}-catenin/E-cadherin complex formation and intercellular adhesion in human breast epithelial cells.
Medrek C; Landberg G; Andersson T; Leandersson K
J Biol Chem; 2009 Apr; 284(16):10968-79. PubMed ID: 19244247
[TBL] [Abstract][Full Text] [Related]
18. Wnt1 expression induces short-range and long-range cell recruitments that modify mammary tumor development and are not induced by a cell-autonomous beta-catenin effector.
Kim YC; Clark RJ; Ranheim EA; Alexander CM
Cancer Res; 2008 Dec; 68(24):10145-53. PubMed ID: 19074881
[TBL] [Abstract][Full Text] [Related]
19. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells.
Png KJ; Halberg N; Yoshida M; Tavazoie SF
Nature; 2011 Dec; 481(7380):190-4. PubMed ID: 22170610
[TBL] [Abstract][Full Text] [Related]
20. Human chorionic gonadotropin (hCG) up-regulates wnt5b and wnt7b in the mammary gland, and hCGbeta transgenic female mice present with mammary Gland tumors exhibiting characteristics of the Wnt/beta-catenin pathway activation.
Kuorelahti A; Rulli S; Huhtaniemi I; Poutanen M
Endocrinology; 2007 Aug; 148(8):3694-703. PubMed ID: 17510243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
